A carregar...
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
BACKGROUND: Rifaximin and lactulose are common effective agents for hepatic encephalopathy (HE). Whether a combination of rifaximin and lactulose improves the efficacy and mortality in patients with HE compared with lactulose alone needs to be analyzed. METHODS: A systematic search was performed in...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6301297/ https://ncbi.nlm.nih.gov/pubmed/30587923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S172324 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|